PUMA BIOTECHNOLOGY, INC. (25) | Uncategorized (5)

Recent Contracts

Open Market Sale AgreementSM, dated November 4, 2021, by and between Puma Biotechnology, Inc. and Jefferies LLC (Filed With SEC on November 4, 2021)
Letter Agreement, dated February 13, 2020, by and between the Company and Jeff J. Ludwig (Filed With SEC on March 1, 2021)
Pfizer Letter Agreement dated June 8, 2020, by and between the Company and Pfizer Inc (Filed With SEC on August 6, 2020)
Description of the Company's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 28, 2020)
Side Letter Agreement, dated November 19, 2018, between the Company and CANbridge Biomed Limited (as successor in interest to CANbridgepharma Limited) (Filed With SEC on March 1, 2019)